A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatide, eloralintide and placebo for body weight reduction in participants with obesity. Participation in the study will last about 2 years.
Epistemonikos ID: c897044b316479e007956f9e75e0878284e497db
First added on: Oct 20, 2026